Brief: Adial Pharmaceuticals Inc - Nasdaq Granted Co Extension Up Until Aug 21 To File A Form 10-Q

Azora Therapeutics

10/07/2023 23:20

July 10 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS INC - NASDAQ GRANTED CO EXTENSION UP
UNTIL
AUG 21 TO FILE A FORM 10-Q REPORT FOR PERIOD ENDED JUNE 30, 2023

Further company coverage:  ADIL.O